Advanced Search

Journal of Traditional Chinese Medicine >

2022 , Vol. 42 >Issue 3: 344 - 352

DOI: https://doi.org/10.19852/j.cnki.jtcm.2022.03.003

Research Article

Fuzheng Kang' ai decoction (扶正抗癌方) inhibits cell proliferation, migration and invasion by modulating mir-21-5p/human phosphatase and tensin homology deleted on chromosome ten in lung cancer cells

  • Jinhua LI ,
  • Chunping LIU ,
  • Yueyang ZHAO ,
  • Wanyin WU ,
  • Pengtao SUN ,
  • Longmei LI ,
  • Xiaobing YANG ,
  • Yushu ZHOU
Expand
  • 1 Department of Ultrasound, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
    2 Department of Ultrasound, Institute of Ultrasound in Musculoskeletal Sports Medicine, Guangdong Second Provincial General Hospital, Guangzhou 510317, China
    3 State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
    4 Department of Hematology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
    5 Department of Oncology, Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
ZHOU Yushu, YANG Xiaobing, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China. zhouyushu819@163.com, yangxiaobing2002@126.com,Telephone: +86-20-81887233

Received date: 2020-12-12

  Accepted date: 2021-02-16

  Online published: 2022-05-20

Supported by

China Postdoctoral Science Foundation(2020M672745);Research Project of Traditional Chinese Medicine Bureau of Guangdong Province(Ultrasound-delivery System to Deliver Solasonine to Regulate miR-141-3p and Enhance the Inhibition of Lung Cancer by Gefitinib)(20201149);National Natural Science Foundation of China of China(Exploring the Mechanism on Reversal of Gefitinib Resistance in Treating Non-Small Cell Lung Cancer by Fuzhengkangai Decoction base on miRNA-206/449a, 81974543: Research on Fuzheng kang'ai Formula Reversing the Drug Resistance to Gefitinib in Non-Small Cell Lung Cancer NSCLC via inducing Ferroptosis by Regulating Ferritin and 81803919: the Molecular Mechanism of Fuzheng Kang-ai Decoction Reversing EMT based on Crosstalk between Tumor and Its Microenvironment)(81503507)

Fold

Abstract

OBJECTIVE: To elucidate the potential molecular mechanism by which Fuzheng Kang’ai decoction (扶正抗癌方, FZKA) inhibits proliferation, migration, and invasion of lung cancer cells.

METHODS: Varying FZKA concentrations were used to manage lung cancer cells (A549 and PC9). We employed: cell counting kit-8 (CCK-8) and plate clone for-mation assays to examine the cell viability; flow cytometry (FCM) to analyze the cycle arrest; transwell and wound-healing assays to assess the cell invasion and migration, respectively. Further, a quantitative real-time polymerase chain reaction (qRT-PCR) assay was adopted to evaluate the miR-21-5p expression. For protein expression analysis, we employed the Western blot technique. Recombinant miR-21-5p overexpression adenovirus vector harboring GFP was constructed and transfected into A549 and PC9, after which we explored the effect of FZKA on miR-21-5p overexpression.

RESULTS: Notably, treatment with FZKA inhibited viability, clone-formation ability, invasion, and migration of lung cancer cells. Mechanistically, FZKA markedly suppressed miR-21-5p expression but elevated the human phosphatase and tensin homology deleted on chromosome ten (PTEN) protein level in both A549 and PC9 cells. Over-expression of miR-21-5p lowered PTEN protein expression. Besides, overexpressed miR-21-5p levels with adenovirus antagonized FZKA-upregulated PTEN protein expression.

CONCLUSION: The present study demonstrates how FZKA modulates cell biological behaviors, for instance, it impedes the proliferation by upregulating PTEN expression with miR-21-5p as the target. These findings unveil the potential novel molecular mechanisms from the microRNA aspect by which FZKA suppresses the growth of human lung cancer cells.

Key words： lung neoplasms; miR-21-5p; PTEN phos-phohydrolase; Fuzheng Kang’ai decoction

Cite this article

Jinhua LI , Chunping LIU , Yueyang ZHAO , Wanyin WU , Pengtao SUN , Longmei LI , Xiaobing YANG , Yushu ZHOU . Fuzheng Kang' ai decoction (扶正抗癌方) inhibits cell proliferation, migration and invasion by modulating mir-21-5p/human phosphatase and tensin homology deleted on chromosome ten in lung cancer cells[J]. Journal of Traditional Chinese Medicine, 2022 , 42(3) : 344 -352 . DOI: 10.19852/j.cnki.jtcm.2022.03.003

References

1 Siegel RL, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70:7-30.
2 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68:7-30.
3 Yap S, Goldsbury D, Yap ML, et al. Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: a population-based study. Lung Cancer Amst Neth 2018; 122:171-9.
4 Huang W. MicroRNAs: biomarkers, diagnostics, and therapeutics. Methods Mol Biol Clifton NJ 2017; 1617:57-67.
5 Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 2016; 17:272-83.
6 Hessam S, Sand M, Skrygan M, Bechara FG. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions. Arch Dermatol Res 2017; 309:557-65.
7 Faraji F, Hu Y, Yang HH, et al. Post-transcriptional control of tumor cell autonomous metastatic potential by CCR4-NOT deadenylase CNOT7. PLoS Genet 2016; 12:e1005820.
8 Sahraei M, Chaube B, Liu Y, et al. Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response. J Clin Invest 2019; 129:5518-36.
9 Bose RJC, Uday Kumar S, Zeng Y, et al. Tumor cell-derived extracellular vesicle-coated nanocarriers: an efficient theranostic platform for the cancer-specific delivery of anti-miR-21 and imaging agents. ACS Nano 2018; 12:10817-32.
10 Cao LQ, Yang XW, Chen YB, Zhang DW, Jiang XF, Xue P. Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth. Mol Cancer 2019; 18:148.
11 Liao J, Shen J, Leng Q, Qin M, Zhan M, Jiang F. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC). Thorac Cancer 2020; 11:762-8
12 Li C, Yin Y, Liu X, Xi X, Xue W, Qu Y. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance. Oncotarget 2017; 8:24564-78.
13 Liang H, Jiao Z, Rong W, et al. 3’-Terminal 2’-O-methylation of lung cancer miR-21-5p enhances its stability and association with Argonaute 2. Nucleic Acids Res 2020; 48:7027-40.
14 Wang G, Zhou Y, Chen W, et al. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2. Cancer Biomark Sect Dis Markers 2020; 28:549-59.
15 Yang C, Sun C, Liang X, Xie S, Huang J, Li D. Integrative analysis of microRNA and mRNA expression profiles in non-small-cell lung cancer. Cancer Gene Ther 2016; 23:90-7.
16 Lee Y-R, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol 2018; 19:547-62.
17 Cai J, Li R, Xu X, et al. CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy. Nat Cell Biol 2018; 20:465-78.
18 VanderLaan PA, Rangachari D, Mockus SM, et al. Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: correlation with clinical outcomes. Lung Cancer Amst Neth 2017; 106:17-21.
19 Tsai C-Y, Wu JCC, Fang C, Chang AYW. PTEN, a negative regulator of PI3K/Akt signaling, sustains brain stem cardiovascular regulation during mevinphos intoxication. Neuropharmacology 2017; 123:175-85.
20 Álvarez-Garcia V, Tawil Y, Wise HM, Leslie NR. Mechanisms of PTEN loss in cancer: it’s all about diversity. Semin Cancer Biol 2019; 59:66-79.
21 Juric D, Castel P, Griffith M, et al. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor. Nature 2015; 518:240-4.
22 Yan L, Wang LZ, Xiao R, et al. Inhibition of microRNA-21-5p reduces keloid fibroblast autophagy and migration by targeting PTEN after electron beam irradiation. Lab Investig J Tech Methods Pathol 2020; 100:387-99.
23 Li N, Wang Z, Gao F, Lei Y, Li Z. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation. J Cell Mol Med 2020; 24:5615-28.
24 Chen J, Zhou C, Li J, et al. miR-21-5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. Int J Mol Med 2018; 41:1855-66.
25 Ren W, Hou J, Yang C, et al. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. J Exp Clin Cancer Res CR 2019; 38:62.
26 Li L, Wang S, Yang X, et al. Traditional Chinese Medicine, Fuzheng Kang-Ai decoction, inhibits metastasis of lung cancer cells through the STAT3/MMP9 pathway. Mol Med Rep 2017; 16:2461-8.
27 Yang XB, Wu WY, Long SQ, et al. Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial. Trials 2015; 16:146.
28 Wang S, Peng Z, Li W, Long S, Xiao S, Wu W. Fuzheng Kang’ai decoction enhances the effect of Gefitinib-induced cell apoptosis in lung cancer through mitochondrial pathway. Cancer Cell Int 2020; 20:185.
29 Zheng F, Wu J, Li X, et al. Chinese herbal medicine Fuzheng Kang’ai decoction inhibited lung cancer cell growth through AMPKα-mediated induction and interplay of IGFBP1 and FOXO3a. Evid-Based Complement Altern Med ECAM 2016; 2016:5060757.
30 Li L, Wang S, Zheng F, Wu W, Hann SS. Chinese herbal medicine Fuzheng Kang’ai decoction sensitized the effect of gefitinib on inhibition of human lung cancer cells through inactivating PI3-K/Akt-mediated suppressing MUC1 expression. J Ethnopharmacol 2016; 194:918-29.
31 Zheng F, Zhao Y, Li X, et al. The repression and reciprocal interaction of DNA methyltrans.ferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib. J Ethnopharmacol 2019; 239:111928.
32 Li L, Wang S, Zheng F, Wu W, Hann SS. Chinese herbal medicine Fuzheng Kang’ai decoction sensitized the effect of gefitinib on inhibition of human lung cancer cells through inactivating PI3-K/Akt-mediated suppressing MUC1 expression. J Ethno-pharmacol 2016; 194:918-29.
33 Calcinotto A, Kohli J, Zagato E, Pellegrini L, Demaria M, Alimonti A. Cellular senescence: aging, cancer, and injury. Physiol Rev 2019; 99:1047-78.
34 Kohsaka S, Petronczki M, Solca F, Maemondo M. Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing. Future Oncol Lond Engl 2019; 15:637-52.
35 Li W, Zheng G, Xia J, et al. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer. Cancer Sci 2018; 109:1012-23.
36 Appert-Collin A, Hubert P, Crémel G, Bennasroune A. Role of ErbB receptors in cancer cell migration and invasion. Front Pharmacol 2015; 6:283.
37 Chen JC, Hsieh YY, Lo HL, Li A, Chou CJ, Yang PM. In vitro and in silico mechanistic insights into mir-21-5p-mediated topoisomerase drug resistance in human colorectal cancer cells. Biomolecules 2019; 9.
38 Tang C, Gu Y, Wang H, et al. Targeting of microRNA-21-5p protects against seizure damage in a kainic acid-induced status epilepticus model via PTEN-mTOR. Epilepsy Res 2018; 144:34-42.
Options
Outlines

/

〈 〉